Market share of generics in selected European countries as of 2016

Market share of generics in European countries 2016 This statistic displays the share of generics in the pharmaceutical market sales value in Europe by selected countries in 2016. The generic share in the pharmaceutical industry's market sales in Denmark exceeded 30 percent in 2016. Market share of generics is higher in newer EU member states due to low levels of intellectual property protection.
Show more
Loading statistic...
Expand statistic
Share of pharmaceutical market sales value
Poland60.4%
Russia57%
Italy56.1%
Bulgaria47%
Croatia42%
Austria40.6%
Turkey39.2%
Hungary37.6%
Germany30.8%
Denmark30.5%
United Kingdom29%
Romania28.1%
Slovenia25.5%
Finland24.2%
Greece23.4%
Spain22.1%
Portugal22%
France19.6%
Ireland19%
Estonia18.9%
Sweden18.6%
Netherlands17.2%
Belgium16.6%
Switzerland13.5%
Share of pharmaceutical market sales value
Poland60.4%
Russia57%
Italy56.1%
Bulgaria47%
Croatia42%
Austria40.6%
Turkey39.2%
Hungary37.6%
Germany30.8%
Denmark30.5%
United Kingdom29%
Romania28.1%
Slovenia25.5%
Finland24.2%
Greece23.4%
Spain22.1%
Portugal22%
France19.6%
Ireland19%
Estonia18.9%
Sweden18.6%
Netherlands17.2%
Belgium16.6%
Switzerland13.5%
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic displays the share of generics in the pharmaceutical market sales value in Europe by selected countries in 2016. The generic share in the pharmaceutical industry's market sales in Denmark exceeded 30 percent in 2016. Market share of generics is higher in newer EU member states due to low levels of intellectual property protection.
Show more
Release date
June 2018
Region
Europe
Survey time period
2016
Supplementary notes
EFPIA: European Federation of Pharmaceutical Industries and Associations
Croatia, Denmark, Estonia, Finland, Greece, United Kingdom: share of generics in pharmacy market sales. Austria, Belgium, Bulgaria, France, Germany, Ireland, Italy, Netherlands, Portugal, Slovenia, Spain: share of generics in reimbursable pharmacy market sales. Czech Republic, Poland, Romania, Russia, Sweden, Switzerland, Turkey: share of generics in total market sales. Cyprus, Hungary, Iceland, Latvia, Lithuania, Malta, Norway, Serbia, Slovakia: 2016 data not available. France: data relate only to those active substances listed on the official list of medicines.

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom

Related Studies: Available to Download in PDF or PPTX Format

Pharmaceutical trends in Europe
Pharmaceutical trends in Europe

All Information
in one Presentation

Pharmaceutical trends in Europe

Everything On "Pharmaceutical trends in Europe" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical trends in Europe"

  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News